Aptuit LLC Names Stuart E. Needleman as President and Chief Operating Officer

19-Mar-2012 - Timothy C. Tyson, Aptuit Chairman, announced that effective immediately, Stuart E. Needleman has been named President and Chief Operating Officer of Aptuit LLC. Following the recent sale of the company's Clinical Trials Supply Business, Mr. Needleman has been promoted from his previous position ...

Aptuit and Siena Biotech Announce Strategic Relationship in Italy

30-Jul-2010 - Aptuit, Inc., and Siena Biotech S.p.A, announced a strategic partnership in which Siena Biotech will take a minority stake in Aptuit’s Italian operations in Verona, Italy, and Aptuit will become a provider of choice for Siena Biotech’s development pipeline. Under the agreement Aptuit and Siena ...

Evotec Completes Divesture of Chemical Development

04-Dec-2007 - Evotec AG announced that it has completed the sale of its Chemical Development Business to Aptuit, Inc. for a total consideration of £ 31.5 million (approx. EUR 44 million) effective November 30, 2007. According to the company, this divestiture allows Evotec to focus even more on its strategy ...

Global Pharmaceutical Development, Inc., Becomes 'Aptuit'

Name Change Sets Stage for New Phase of Company Growth and Investment

11-Jul-2005 - Aptuit, Inc. is the new name of an emerging company focused on streamlining and supporting the drug development process for biotechnology and pharmaceutical innovators, the founders announced today. The company was formerly called Global Pharmaceutical Development, Inc. The name change coincides ...